FDA issued a Warning Letter to Hillestad Pharmaceuticals USA, Inc. on 4/17/2013 as a result of this inspection.
483 Hillestad Pharmaceuticals USA May 2012

483 Hillestad Pharmaceuticals USA May 2012

Justin Boyd FDA$119.00 - Available Now

FDA investigators audited the Hillestad Pharmaceuticals USA - Woodruff, WI, United States facility and issued inspectional observations (via FDA 483) on 27 May 2012.

Product details

  • Category: Foods & Cosmetics / Human Drugs
  • Inspection end: 27 May 2012
  • Location: Woodruff, United States
  • FEI: 2917045
Add To Cart